IF by specialty › Oncology
Radiotherapy and Oncology — Impact Factor
The 2025 Impact Factor of Radiotherapy and Oncology is 5.8 (quartile not confirmed; subscription or hybrid).
- Impact Factor
- 5.8 JCR 2025
- JCR category
- Oncology
- Quartile
- quartile not confirmed
- Publisher
- Elsevier (ESTRO)
- Open access
- subscription or hybrid
- IF source
- bioxbio.com
Position within the field
Ranked 24 of the 42 journals in Oncology on this site (bottom 50%).
Oncology journals with a similar Impact Factor
- Critical Reviews in Oncology/Hematology IF 6.2
- Gastric Cancer IF 6.1
- Cancer IF 5.6
- JCO Oncology Practice IF 5.5
- Lung Cancer IF 5.3
- International Journal of Cancer IF 4.9
About this value
The Journal Impact Factor of Radiotherapy and Oncology (JCR 2025, released June 2026) is 5.8. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Oncology.